What is it?
Zinc is an essential mineral that is a component of more than 300 enzymes needed to repair wounds, maintain fertility in adults and growth
in children, synthesise protein, help cells reproduce, preserve vision, boost immunity, and protect against free radicals, among other functions.
In double-blind trials, zinc lozenges have reduced the duration of colds in adults,1 2 3
but have been ineffective in children.4 The ability of zinc to shorten colds may be
due to a direct, localized anti-viral action in the throat. For the alleviation of cold symptoms, lozenges providing 13–25 mg of
zinc, in the form of zinc gluconate, zinc gluconate-glycine, or zinc acetate, are used,
typically every two hours while awake, but only for several days. The best effect is obtained
when lozenges are used at the first sign of a cold.
Lozenges containing zinc gluconate, zinc gluconate-glycine, or zinc acetate have been
effective, whereas most other forms of zinc and lozenges flavored with citric
acid,5 tartaric acid, sorbitol, or mannitol, have been ineffective.6
Trials using forms other than zinc gluconate, zinc gluconate-glycine, or zinc acetate have
failed, as have trials that use insufficient amounts of zinc.7 Therefore, until
more is known, people should only use zinc gluconate, zinc gluconate-glycine, or zinc
acetate.
Zinc reduces the body’s ability to utilise the essential mineral copper. (For healthy people, this interference is
circumvented by supplementing with copper, along with zinc.) The ability to interfere with
copper makes zinc an important therapeutic tool for people with Wilson’s disease—a genetic condition that
causes copper overload.
Zinc supplementation in children in developing countries is associated with improvements in
stunted growth, increased weight gain in underweight children, and substantial reductions in
the rates of diarrhoea and pneumonia, the two
leading causes of death in these settings.8 9 10 Whether such
supplementation would help people in better nourished populations remains unclear.
A small, preliminary trial has found zinc sulphate to be effective for contact dermatitis
(a skin rash caused by contact with an
allergen or irritant).11 Participants with active skin rashes took
approximately 23 mg of zinc (in the form of zinc sulphate) three times daily, for one month.
73% of those taking the zinc sulphate had complete resolution of their skin rashes, while the
remaining participants had a 50–75% improvement. Further trials are needed to confirm
these preliminary findings, however.
Are there any side effects or interactions?
Zinc intake in excess of 300 mg per day has been reported to impair immune function.22 Some people report that
zinc lozenges lead to stomach ache, nausea, mouth irritation, and a bad taste. One source
reports that gastrointestinal upset, metallic taste in the mouth, blood in the urine, and
lethargy can occur from chronic oral zinc supplementation over 150 mg per day,23
but those claims are unsubstantiated. In topical form, zinc has no known side effects when
used as recommended. However, using zinc nasal spray has been reported to cause severe or
complete loss of smell function in at least ten people. In some of those cases, the loss of
smell was long-lasting or permanent.24
Preliminary research had suggested that people with Alzheimer’s disease should avoid zinc
supplements.25 More recently, preliminary evidence in four patients actually showed
improved mental function with zinc supplementation.26 In a convincing review of
zinc/Alzheimer’s disease research, perhaps the most respected zinc researcher in the
world concluded that zinc does not cause or exacerbate Alzheimer’s disease
symptoms.27
Zinc inhibits copper absorption. Copper
deficiency can result in anaemia, lower levels of HDL (“good”) cholesterol, or cardiac arrhythmias.28 29
30 Copper intake should be increased if zinc supplementation continues for more than a
few days (except for people with Wilson’s
disease).31 Some sources recommend a 10:1 ratio of zinc to copper. Evidence
suggests that no more that 2 mg of copper per day is needed to prevent zinc-induced copper
deficiency. Many zinc supplements include copper in the formulation to prevent zinc-induced
copper deficiency. Zinc-induced copper deficiency has been reported to cause reversible
anaemia and suppression of bone marrow.32
Marginal zinc deficiency may be a contributing factor in some cases of anaemia. In a study
of women with normocytic anaemia (i.e., their red blood cells were of normal size) and low
total iron-binding capacity (a blood test often used to assess the cause of anaemia), combined
iron and zinc supplementation significantly
improved the anaemia, whereas iron or zinc supplemented alone had only slight
effects.33 Supplementation with zinc, or zinc and iron together, has been found to improve vitamin A status among children at high risk for
deficiency of the three nutrients.34
Zinc competes for absorption with copper,
iron,35 36 calcium,37 and magnesium.38 A multimineral supplement will help prevent mineral
imbalances that can result from taking high amounts of zinc for extended periods of time.
N-acetyl cysteine (NAC) may increase
urinary excretion of zinc.39 Long-term users of NAC may consider adding supplements
of zinc and copper.
Are there any drug
interactions?
Certain medicines may interact with zinc. Refer to drug interactions for a list of those medicines.
1. Mossad SB, Macknin ML, Medendorp SV, et al. Zinc gluconate lozenges
for treating the common cold. Ann Intern Med 1996;125:81–8.
2. Anonymous. Zinc lozenges reduce the duration of common cold symptoms.
Nutr Rev 1997;55:82–8 [review].
3. Garland ML, Hagmeyer KO. The role of zinc lozenges in treatment of the
common cold. Ann Pharmacother 1998;32:93–69 [review].
4. Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges
for treating the common cold in children. A randomized controlled trial. JAMA
1998;279:1962–7.
5. Eby G. Where’s the bias? Ann Intern Med 1998;128:75
[letter].
6. Garland ML, Hagmeyer KO. The role of zinc lozenges in treatment of the
common cold. Ann Pharmacother 1998;32:63–9 [review].
7. Weismann K, Jakobsen JP, Weismann JE, et al. Zinc gluconate lozenges
for common cold. A double-blind clinical trial. Dan Med Bull
1990;37:279–81.
8. Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and
pneumonia by zinc supplementation in children in developing countries: pooled analysis of
randomized controlled trials. Zinc Investigators’ Collaborative Group. J
Pediatr 1999;135:689–97.
9. Umeta M, West CE, Haidar J, et al. Zinc supplementation and stunted
infants in Ethiopia: a randomised controlled trial. Lancet 2000;355:2021–6.
10. Gibson RS. Zinc supplementation for infants. Lancet
2000;355:2008–9.
11. Santucci B, Cristaudo A, Mehraban M, et al. ZnSO4 treatment of
NiSO4-positive patients. Contact Dermatitis 1999;40:281–2.
12. Cherry FF, Sandstead HH, Rojas P, et al. Adolescent pregnancy:
associations among body weight, zinc nutriture, and pregnancy outcome. Am J Clin Nutr
1989;50:945–54.
13. Goldenberg RL, Tamura T, Neggers Y, et al. The effect of zinc
supplementation on pregnancy outcome. JAMA 1995;274:463–8.
14. Scholmerich J, Lohla E, Gerok W. Zinc and vitamin A deficiency in
liver cirrhosis. Hepatogastroenterology 1983;30:119–25.
15. Karayalcin S, Arcasoy A, Uzunalimoglu O. Zinc plasma levels after
oral zinc tolerance test in nonalcoholic cirrhosis. Dig Dis Sci
1988;33:1096–102.
16. Stabile A, Pesaresi MA, Stabile AM, et al. Immunodeficiency and
plasma zinc levels in children with Down’s syndrome: a long-term follow-up of oral zinc
supplementation. Clin Immunol Immunopathol 1991;58:207–16.
17. Björksten B, Back O, Gustavson KH, et al. Zinc and immune
function in Down’s syndrome. Acta Paediatr Scand 1980;69:183–7.
18. Bucci I, Napolitano G, Guiliani C, et al. Zinc sulfate
supplementation improves thyroid function in hypozincemic Down children. Biol Trace Elem
Res 1999;67;257–68.
19. Wollowa F, Jablonska S. Zinc in the treatment of alopecia areata. In:
Kobori Y, Montagna W (eds). Biology and Diseases of the Hair. Tokyo: University Park
Press, 1976, 305.
20. Lutz G. The value of zinc in treatment of alopecia areata. 2nd
Meeting of the European Hair Research Society, Bologna, April 14, 1991.
21. Prasad A. Discovery of human zinc deficiency and studies in an
experimental human model. Am J Clin Nutr 1991;53:403–12 [review].
22. Chandra RK. Excessive intake of zinc impairs immune responses.
JAMA 1984;252:1443.
23. Shannon M. Alternative medicines toxicology: a review of selected
agents. Clin Toxicol 1999;37:709–13
24. Jafek BW, Linschoten MR, Murrow BW. Anosmia after intranasal zinc
gluconate use. Am J Rhinol 2004;18:137–41.
25. Bush AI, Pettingell WH, Multhaup G, et al. Rapid induction of
Alzheimer A8 amyloid formation by zinc. Science 1994;265:1464–5.
26. Potocnik FCV, van Rensburg SJ, Park C, et al. Zinc and platelet
membrane microviscosity in Alzheimer’s disease. S Afr Med J
1997;87:1116–9.
27. Prasad AS. Zinc in human health: an update. J Trace Elem Exp
Med 1998;11:63–87.
28. Broun ER, Greist A, Tricot G, Hoffman R. Excessive zinc ingestion-a
reversible cause of sideroblastic anemia and bone marrow depression. JAMA
1990;264:1441–3.
29. Reiser S, Powell A, Yang CY, Canary JJ. Effect of copper intake on
blood cholesterol and its lipoprotein distribution in men. Nutr Rep Int
1987;36:641–9.
30. Sandstead HH. Requirements and toxicity of essential trace elements,
illustrated by zinc and copper. Am J Clin Nutr 1995;61(suppl):621S–24S
[review].
31. Fischer PWF, Giroux A, Labbe MR. Effect of zinc supplementation on
copper status in adult man. Am J Clin Nutr 1984;40:743–6.
32. Broun ER, Greist A, Tricot G, Hoffman R. Excessive zinc ingestion. A
reversible cause of sideroblastic anemia and bone marrow depression. JAMA
1990;264:1441–3.
33. Nishiyama S, Irisa K, Matsubasa T, et al. Zinc status relates to
hematological deficits in middle-aged women. J Am Coll Nutr 1998;17:291–5.
34. Muñoz EC, Rosado JL, Lopez P, et al. Iron and zinc
supplementation improves indicators of vitamin A status of Mexican preschoolers. Am J Clin
Nutr 2000;71:789–94.
35. Dawson EB, Albers J, McGanity WJ. Serum zinc changes due to iron
supplementation in teen-age pregnancy. Am J Clin Nutr 1990;50:848–52.
36. Crofton RW, Gvozdanovic D, Gvozdanovic S, et al. Inorganic zinc and
the intestinal absorption of ferrous iron. Am J Clin Nutr 1989;50:141–4.
37. Argiratos V, Samman S. The effect of calcium carbonate and calcium
citrate on the absorption of zinc in healthy female subjects. Eur J Clin Nutr
1994;48:198–204.
38. Spencer H, Norris C, Williams D. Inhibitory effects of zinc on
magnesium balance and magnesium absorption in man. J Am Coll Nutr
1994;13:479–84.
39. Brumas V, Hacht B, Filella M, Berthon G. Can N-acetyl-L-cysteine
affect zinc metabolisms when used as a paracetamol antidote? Agents Actions
1992;36:278–88.